Journal of Diagnostics Concepts & Practice >
Study on correlation of cardiac magnetic resonance strain rate parameters of left ventricular diastolic function with risk of sudden death in hypertrophic cardiomyopathy
Received date: 2022-01-05
Online published: 2022-08-17
Objective: To investigate the relationship between cardiac magnetic resonance(CMR) myocardial strain rate (SR) parameters of left ventricular diastolic function and the risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). Methods: A total of 160 HCM patients and 50 healthy control subjects who underwent CMR were enrolled. Radial strain rate (RSR), circumferential strain rate (CSR) and longitudinal strain rate(LSR) of left ventricle (LV) by CMR were measured. Risk stratification of SCD by 2014 European Society of Cardiology(ESC) and the 2020 American College of Cardiology/American Heart Association (ACC/AHA) guidelines were performed in patients respectively. Differences in diastolic function between high-risk and low-risk groups under the same guideline were compared with t test and one-way ANOVA was used to compare diastolic function between subgroups based on two guidelines. Linear regression analysis was performed to analyze the association of commonly risk factors in guidelines and diastolic function. Results: The absolute value of diastolic SR of LV in HCM was significantly decreased when compared with those of control subjects (RSR: -1.27 ± 0.60 vs -2.40 ± 0.59, CSR: 0.71 ± 0.24 vs 1.22 ± 0.25, LSR: 0.52 ± 0.24 vs 0.89 ± 0.20, all P<0.05). There were significant differences in diastolic RSR and CSR among HCM different phenotypes (all P<0.05). Patients with high SCD risk (n=27) according to the 2014 ESC guidelines had significantly lower diastolic RSR(P<0.05) than those with low SCD risk,while had no difference in CSR and LSR. Patients with high SCD risk (n=92) according to the 2020 ACC/AHA guidelines had significantly lower diastolic SR(RSR, CSR and LSR) (all P<0.05) than those with low SCD risk. The diastolic SR in patients with low SCD risk by 2014 ESC but high SCD risk by ACC/AHA were similar with patients at high risk based on both guidelines, and were significantly lower than that of patients at low risk in both guidelines. Among the four major risk factors, the absolute value of diastolic myocardial SR were significantly decreased in the group which had higher maximum left ventricular wall thickness (≥30 mm) and late gadolinium enhancement/left ventricle mass (≥15%), and LV diastolic function was severely impaired. Maximum left ventricular wall thickness and late gadolinium enhancement/left ventricle mass both had significant association with diastolic myocardial SR (correlation coefficient r were 0.48/0.35 in RSR, -0.42/-0.31 in CSR, -0.37/-0.16 in LSR, all P<0.05). Conclusions: SR of LV myocardial by CMR is significantly reduced in patients at high risk of SCD, and is correlated with some risk factors, which may serve as a new biomarker to assist the stratification of SCD risk.
LIU Peng, YAN Fuhua, QIN Le, XIAO Ruijie . Study on correlation of cardiac magnetic resonance strain rate parameters of left ventricular diastolic function with risk of sudden death in hypertrophic cardiomyopathy[J]. Journal of Diagnostics Concepts & Practice, 2022 , 21(03) : 317 -325 . DOI: 10.16150/j.1671-2870.2022.03.005
[1] | 中国医师协会心力衰竭专业委员会, 中华心力衰竭和心肌病杂志编辑委员会. 中国肥厚型心肌病管理指南2017[J]. 中华心力衰竭和心肌病杂志(中英文), 2017, 1(2):65-86. |
[1] | Heart Failure Professional Commi of Chinese Medical Docter Association, Eolitorial Board of Chinese Journal of Heart Failure and Cardiomyopathy. Eolitorial Board of Chinese Journal of Heart Failure and Cardiomyopathy. Chinese guildelines on the management of hypertrophic cardimyopathy 2017[J]. Chin J Heart Fail & Cardiomyopathy, 2017, 1(2):65-86. |
[2] | 雷晓琳, 陈石(综述), 陈玉成(审校). 心脏磁共振成像新技术及其在肥厚型心肌病研究中的应用[J]. 心血管病学进展, 2015(4):483-487. |
[2] | Lei XL, Chen S, Chen YC. Cardiac magnetic resonance new technologies and its application for investigation in hypertrophic cardiomyopathy[J]. Advances in Cardiovascular Diseases, 2015, 36(4):483-487. |
[3] | Scatteia A, Baritussio A, Bucciarelli-Ducci C. Strain imaging using cardiac magnetic resonance[J]. Heart Fail Rev, 2017, 22(4):465-476. |
[4] | 李亚萍, 赵蕾, 范占明. MR应变成像技术在心脏疾病中的应用[J]. 中国医学影像技术, 2018, 34(4):621-624. |
[4] | Li YP, Zhao L, Fan ZM. Application of MR strain ima-ging in cardiac diseases[J]. Chinese Journal of Medical Imaging Technology, 2018, 34(4):621-624. |
[5] | Swoboda PP, McDiarmid AK, Erhayiem B, et al. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy[J]. J Cardiovasc Magn Reson, 2017, 19(1):16. |
[6] | 徐刚. 心脏磁共振在肥厚型心肌病中的临床应用研究[D]. 第三军医大学, 2015. |
[6] | Xu G. Clinical application study of cardiac magnetic reso-nance on hypertrophic cardiomyopathy[D]. Army Medical University, 2015. |
[7] | Chen S, Yuan J, Qiao S, et al. Evaluation of left ventri-cular diastolic function by global strain rate imaging in patients with obstructive hypertrophic cardiomyopathy: a simultaneous speckle tracking echocardiography and cardiac catheterization study[J]. Echocardiography, 2014, 31(5):615-622. |
[8] | Baxi AJ, Restrepo CS, Vargas D, et al. Hypertrophic cardiomyopathy from A to Z: cenetics, pathophysiology, imaging, and management[J]. Radiographics, 2016, 36(2):335-354. |
[9] | Authors/Task Force members, Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2014, 35(39):2733-2779. |
[10] | Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. CJ Am Coll Cardiol, 2020, 76(25):e159-e240. |
[11] | Smiseth OA, Torp H, Opdahl A, et al. Myocardial strain imaging: how useful is it in clinical decision making?[J]. Eur Heart J, 2016, 37(15):1196-1207. |
[12] | Zhu L, Gu S, Wang Q, et al. Left ventricular myocardial deformation: a study on diastolic function in the Chinese male population and its relationship with fat distribution[J]. Quant Imaging Med Surg, 2020, 10(3):634-645. |
[13] | Kermer J, Traber J, Utz W, et al. Assessment of diastolic dysfunction: comparison of different cardiovascular magnetic resonance techniques[J]. ESC Heart Fail, 2020, 7(5):2637-2649. |
[14] | Kuo JY, Chang SH, Sung KT, et al. Left ventricular dysfunction in atrial fibrillation and heart failure risk[J]. ESC Heart Fail, 2020, 7(6):3694-3706. |
[15] | Maron MS, Rowin EJ, Wessler BS, et al. Enhanced American College of Cardiology/American Heart Association Strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy[J]. JAMA Cardiol, 2019, 4(7):644-657. |
[16] | Lin TT, Wang YC, Juang JJ, et al. Application of the newest European Association of Cardiovascular Imaging Recommendation regarding the long-term prognostic relevance of left ventricular diastolic function in heart failure with preserved ejection fraction[J]. Eur Radiol, 2020, 30(1):630-639. |
[17] | Yokoi T, Morimoto R, Oishi H, et al. Left ventricular relaxation half-time as a predictor of cardiac events in idiopathic dilated cardiomyopathy and hypertrophic cardiomyopathy with Left ventricular systolic and/or diastolic dysfunction[J]. Am J Cardiol, 2019, 124(3):435-441. |
[18] | Villemain O, Correia M, Mousseaux E, et al. Myocardial stiffness evaluation using noninvasive shear wave imaging in healthy and hypertrophic cardiomyopathic adults[J]. JACC Cardiovasc Imaging, 2019, 12(7 Pt 1):1135-1145. |
[19] | Chacko BR, Karur GR, Connelly KA, et al. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy[J]. Indian Heart J, 2018, 70(1):75-81. |
[20] | Yang H, Carasso S, Woo A, et al. Hypertrophy pattern and regional myocardial mechanics are related in septal and apical hypertrophic cardiomyopathy[J]. J Am Soc Echocardiogr, 2010, 23(10):1081-1089. |
[21] | Kim EK, Lee SC, Hwang JW, et al. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(6):678-686. |
[22] | Villa AD, Sammut E, Zarinabad N, et al. Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement[J]. J Cardiovasc Magn Reson, 2016, 18:4. |
[23] | Ellims AH, Iles LM, Ling LH, et al. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction[J]. J Cardiovasc Magn Reson, 2012, 14(1):76. |
[24] | Kanagala P, Cheng ASH, Singh A, et al. Relationship between focal and diffuse fibrosis assessed by CMR and clinical outcomes in heart failure with preserved ejection graction[J]. JACC Cardiovasc Imaging, 2019, 12(11 Pt 2):2291-2301. |
[25] | Avegliano G, Politi MT, Costabel JP, et al. Differences in the extent of fibrosis in obstructive and nonobstructive hypertrophic cardiomyopathy[J]. J Cardiovasc Med (Hagerstown), 2019, 20(6):389-396. |
[26] | Satriano A, Heydari B, Guron N, et al. 3-Dimensional regional and global strain abnormalities in hypertrophic cardiomyopathy[J]. Int J Cardiovasc Imaging, 2019, 35(10):1913-1924. |
/
〈 |
|
〉 |